Platelet surface glycoprotein expression in post-stroke depression: A preliminary study

Psychiatry Research

Volumn 118, Issue 2, 2003, Pages 175-181

  Cassidy, Eugene M ^a,e   Walsh, Marie Therese ^a   O'Connor, Rory ^b   Condren, Rita M ^a   Ryan, Martina ^a   O'Keane, Veronica ^a,d   Kenny, Dermot ^a   Dinan, Timothy ^c  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b The National Rehabilitation Hospital   (Ireland)

^c University College Cork and INFANT Centre   (Ireland)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Activation; Depression; Flow cytometry; GPIb; GPIIbIIIa; Morbidity; Stroke

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEIN IB; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; RECEPTOR PROTEIN;

ADULT; ARTICLE; BLOOD; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; PATHOPHYSIOLOGY; POPULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SAMPLE; STROKE; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE DYSFUNCTION; THROMBOCYTE MEMBRANE;

EID: 0038546375     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(03)00062-3     Document Type: Article

References (35)

1. Afshar-Kharghan V., Khoshnevis-Asl M., Hopkins P., Lopez J.A. Polymorphisms of the platelet glycoprotein (GP) Iba kozak sequence determines the surface level of the GP-1b-IX-V complex and risk for early myocardial infarction. Blood. 92:1998;A2887.
2. Anda R., Williamson D., Jones D., Macera C., Eaker E., Glassman A., Marks J. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults. Epidemiology. 4:1993;285-294.
3. Astrom M., Adolfsson R., Asplund K. Major depression in stroke patients: a 3-year longitudinal study. Stroke. 24:1993;976-982.
4. Barefoot J.C., Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation. 93:1996;1976-1980.
5. Blumenthal J.A., Williams R.S., Wallace A.G., Williams R.B. Jr., Needles T.L. Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction. Psychosomatic Medicine. 44:1982;519-529.
6. Carney R.M., Freedland K.E., Eisen S.A., Rich M.W., Jaffe A.S. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychology. 14:1995;88-90.
7. Escolar G., White J.G. Changes in glycoprotein expression after platelet activation: differences between in vitro and in vivo studies. Thrombosis and Haemostasis. 83:2000;371-386.
8. Everson S.A., Roberts R.E., Goldberg D.E., Kaplan G.A. Depressive symptoms and increased risk of mortality over a 29-year period. Archives of Internal Medicine. 158:1998;1133-1138.
9. Figiel G.S., Krishnan K.R.R., Doraiswamy P.M., Rao V.P., Nemeroff C.B., Boyko O.B. Subcortical hyperintensities on brain magnetic resonance imaging: a comparison between late age onset and early onset elderly depressed subjects. Neurobiology and Aging. 26:1991;245-247.
10. Frasure-Smith N., Lesperance F., Talajic M. Depression following myocardial infarction: impact on 6-month survival. Journal of the American Medical Association. 270:1993;1819-1825.
11. Fujikawa T., Yamawaki S., Touhouda Y. Incidence of silent cerebral infarction in patients with major depression. Stroke. 24:1993;1631-1634.
12. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry. 23:1960;56-62.
13. Horner R.D. The high cost of stroke to society, the family, and the patient. Pharmacotherapy. 18:1998;87-93.
14. House A., Knapp P., Bamford J., Vail A. Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month. Stroke. 32:2001;696-701.
15. Jonas B.S., Mussolino M.E. Symptoms of depression as a prospective risk factor for stroke. Psychosomatic Medicine. 62:2000;463-471.
16. Kenny D., Muckian C., Fitzgerald D.J., Cannon C.P., Shields D.C. Platelet glycoprotein Ib alpha receptor polymorphisms and recurrent ischaemic events in acute coronary syndrome patients. J Thromb Thrombolysis. 13:2002;13-19.
17. Konstantopoulos K., Grotta J.C., Sills C., Wu K.K., Hellums J.D. Shear-induced platelet aggregation in normal subjects and stroke patients. Thrombosis and Haemostasis. 74:1995;1329-1334.
18. Laghrissi-Thode F., Wagner W.R., Pollock B.G., Johnson P.C., Finkel M.S. Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biological Psychiatry. 42:1997;290-295.
19. Lederbogen F., Gilles M., Maras A., Hamann B., Colla M., Heuser I., Deuschle M. Increased platelet aggregability in major depression? Psychiatry Research. 102:2001;255-261.
20. Lefkovits J., Plow E.F., Topol E.J. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. New England Journal of Medicine. 332:1995;1553-1559.
21. Markowitz J.H., Matthews K.A. Platelets and coronary heart disease: potential pathophysiological mechanisms. Psychosomatic Medicine. 53:1991;643-668.
22. Markowitz J.H., Shuster J.L., Chitwood W.S., May R.S., Tolbert L.C. Platelet activation in depression and effects of sertraline treatment: an open label study. American Journal of Psychiatry. 157:2000;1006-1008.
23. Michelson A.D., Barnard M.R., Krueger L.A., Frelinger A.L. III, Furman M.I. Evaluation of platelet function by flow cytometry. Methods. 21:2000;259-270.
24. Morris P.L., Raphael B., Robinson R.G. Clinical depression is associated with impaired recovery from stroke. Medical Journal of Australia. 157:1992;239-242.
25. Morris P.L., Robinson R.G., Andrzejewski P., Samuels J., Price T.R. Association of depression with 10-year poststroke mortality. American Journal of Psychiatry. 150:1993;124-129.
26. Musselman D.L., Marzec U.M., Manatunga A., Penna S., Reemsnyder A., Knight B.T., Baron A., Hanson S.R., Nemeroff C.B. Platelet reactivity in depressed patients treated with paroxetine. Archives in General Psychiatry. 57:2000;875-882.
27. Musselman D.L., Tomer A., Manatunga A.K., Knight, Porter M.R., Kasey S., Marzec U., Harker L.A., Nemeroff C.B. Exaggerated platelet reactivity in major depression. American Journal of Psychiatry. 153:1996;1313-1317.
28. Nishio K., Fujimura Y., Niinomi K., Takahashi Y., Yoshioka A., Fukui H., Usami Y., Titani K., Ruggeri Z.M., Zimmerman T.S. Enhanced botrocetin-induced type IIB von Willebrand factor binding to platelet glycoprotein Ib initiates hyperagglutination of normal platelets. American Journal of Haematology. 33:1990;261-266.
29. Parikh R.M., Robinson R.G., Lipsey J.R., Starkstein S.E., Fedoroff J.P., Price T.R. The impact of poststroke depression on recovery in activities of daily living over a 2-year follow-up. Archives of Neurology. 47:1990;785-789.
30. Pollock B.G., Laghrissi-Thode F., Wagner W.R. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. Journal of Clinical Psychopharmacology. 20:2000;137-140.
31. Quinn M.J., Cox D., Foley J.B., Fitzgerald D.J. Glycoprotein IIb/IIIa receptor number and occupancy during chronic administration of an oral antagonist. Journal of Pharmacology and Experimental Therapeutics. 295:2000;670-676.
32. Simons L.A., McCallum J., Friedlander Y., Simons J. Risk factors for ischemic stroke: Dubbo study of the elderly. Stroke. 29:1998;1341-1346.
33. Smith N.M., Pathansali R., Bath P.M. Platelets and stroke. Vascular Medicine. 4:1999;165-172.
34. Walsh M.T., Dinan T.G., Condren R.M., Ryan M., Kenny D. Depression is associated with an increase in the expression of the platelet adhesion receptor glycoprotein Ib. Life Sciences. 70:(26):2002;3155-3165.
35. Weksler B.B. Antiplatelet agents in stroke prevention. Combination therapy: present and future. Cerebrovascular Disease. 10:(Supplement S5):2000;41-48.